Enprani Co., Ltd. – FDA Inspection, Mar 15, 2019

Record Details

This FDA Inspection record concerns Enprani Co., Ltd., with an inspection on March 15, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Enprani Co., Ltd.
Inspection Date: March 15, 2019
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Rumany C. Penn (FDA Associated Person)

View Company Profile

ID · e8dd105b-dd90-4d52-a1fb-82d81b13bc2f

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number: 1085302
FDA center: Human Drugs
Project area: Drug Quality Assurance
Outcome: Form 483 issued
Enforcement: Warning Letter

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Enprani Co., Ltd.

FDA Inspection

Enprani Co., Ltd.March 15, 2019